Cargando…
The value of comprehensive genomic sequencing to maximize the identification of clinically actionable alterations in advanced cancer patients: a case series
Purpose: We present seven cases of advanced cancer patients who initially underwent tumor testing utilizing smaller, panel-based tests, followed by a variety of therapeutic treatments which ultimately resulted in progression of their disease. These cases demonstrate the value of utilizing WES/RNA se...
Autores principales: | Drenner, Kevin, Basu, Gargi D., Goodman, Laurie J., Ozols, Audrey A., LoBello, Janine R., Royce, Thomas, Gordon, Michael S., Borazanci, Erkut H., Steinbach, Margaux A., Trent, Jeffrey, Sharma, Sunil |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8416559/ https://www.ncbi.nlm.nih.gov/pubmed/34504655 http://dx.doi.org/10.18632/oncotarget.28046 |
Ejemplares similares
-
Addendum: The value of comprehensive genomic sequencing to maximize the identification of clinically actionable alterations in advanced cancer patients: a case series
por: Drenner, Kevin, et al.
Publicado: (2022) -
Analytic validation and clinical utilization of the comprehensive genomic profiling test, GEM ExTra(®)
por: White, Tracey, et al.
Publicado: (2021) -
A rare case of sporadic mismatch repair deficient pancreatic ductal adenocarcinoma that responded to ipilimumab and nivolumab combination treatment: case report
por: Han, Margaret Y., et al.
Publicado: (2023) -
Malignant ascites in pancreatic cancer: Pathophysiology, diagnosis, molecular characterization, and therapeutic strategies
por: Han, Margaret Y., et al.
Publicado: (2023) -
A Case Report of Immunotherapy-Resistant MSI-H Gastric Cancer with Significant Intrapatient Tumoral Heterogeneity Characterized by Histologic Dedifferentiation
por: Kethireddy, Nikhila, et al.
Publicado: (2022)